Bioceres Crop Solutions Corp. (NASDAQ:BIOX) Given Average Rating of “Buy” by Analysts

Shares of Bioceres Crop Solutions Corp. (NASDAQ:BIOX) have received an average recommendation of “Buy” from the six analysts that are currently covering the stock, Marketbeat Ratings reports. Four research analysts have rated the stock with a buy recommendation and two have assigned a strong buy recommendation to the company. The average 1-year price objective among analysts that have issued ratings on the stock in the last year is $12.13.

BIOX has been the topic of several research reports. Oppenheimer dropped their price target on Bioceres Crop Solutions from $16.00 to $13.00 and set an “outperform” rating on the stock in a research report on Monday, October 21st. Canaccord Genuity Group reduced their price target on shares of Bioceres Crop Solutions from $10.00 to $9.50 and set a “buy” rating on the stock in a research report on Wednesday, November 13th.

Bioceres Crop Solutions Price Performance

Shares of BIOX stock opened at $6.89 on Tuesday. The firm has a fifty day moving average of $6.58 and a two-hundred day moving average of $8.25. The firm has a market cap of $432.08 million, a P/E ratio of 344.67 and a beta of 0.56. Bioceres Crop Solutions has a 1-year low of $5.71 and a 1-year high of $14.05. The company has a debt-to-equity ratio of 0.37, a current ratio of 1.27 and a quick ratio of 0.87.

Bioceres Crop Solutions (NASDAQ:BIOX) last announced its quarterly earnings data on Monday, November 11th. The company reported ($0.09) earnings per share for the quarter, missing the consensus estimate of $0.02 by ($0.11). Bioceres Crop Solutions had a net margin of 0.53% and a return on equity of 0.68%. The firm had revenue of $92.60 million during the quarter, compared to the consensus estimate of $117.15 million. During the same period in the prior year, the firm earned ($0.07) earnings per share. As a group, research analysts anticipate that Bioceres Crop Solutions will post 0.12 earnings per share for the current fiscal year.

Hedge Funds Weigh In On Bioceres Crop Solutions

Several institutional investors have recently modified their holdings of the company. Dimensional Fund Advisors LP lifted its position in Bioceres Crop Solutions by 9.5% in the 2nd quarter. Dimensional Fund Advisors LP now owns 61,330 shares of the company’s stock valued at $688,000 after purchasing an additional 5,341 shares during the last quarter. Fourth Sail Capital LP raised its holdings in shares of Bioceres Crop Solutions by 20.5% during the second quarter. Fourth Sail Capital LP now owns 1,961,825 shares of the company’s stock valued at $21,992,000 after buying an additional 334,195 shares during the last quarter. Long Focus Capital Management LLC boosted its position in shares of Bioceres Crop Solutions by 19.9% during the second quarter. Long Focus Capital Management LLC now owns 280,547 shares of the company’s stock worth $3,145,000 after buying an additional 46,647 shares during the period. Stifel Financial Corp grew its holdings in Bioceres Crop Solutions by 33.4% in the 3rd quarter. Stifel Financial Corp now owns 40,790 shares of the company’s stock worth $321,000 after buying an additional 10,224 shares in the last quarter. Finally, JPMorgan Chase & Co. increased its position in Bioceres Crop Solutions by 49.3% in the 3rd quarter. JPMorgan Chase & Co. now owns 89,973 shares of the company’s stock valued at $708,000 after acquiring an additional 29,693 shares during the period. Institutional investors own 17.68% of the company’s stock.

Bioceres Crop Solutions Company Profile

Bioceres Crop Solutions Corp., together with its subsidiaries, provides crop productivity solutions. It operates through Seed and Integrated Products, Crop Protection, and Crop Nutrition segments. The Seed and Integrated Products segment provides seed traits, germplasms, and seed treatment packs for healthier, and higher yielding crops.